The Metabolomics Platform (RRID: SCR_022932) was supported by the University of Chicago Comprehensive Cancer Center Support Grant (P30 CA014599)
For short-term storage (a few weeks), a cool, dark place like a cupboard is sufficient
The nephropathic cystinosis fibroblasts (GM00706) and the healthy individual fibroblasts (GM05658) were obtained from Coriell Institute for Medical Research
Lux Glow may be sequenced with peels, laser, microneedling, or medical-grade home care, and it pairs naturally with our other signature treatments: DNA Renewal for fine lines and texture, or Eye Luminance for the under-eye area
Retatrutide FDA Approval 20252026: Phase 3 Trials, Timeline & Access Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, giving it a mechanistic profile no approved drug currently matches